Polytussin DM Interactions
There are 544 drugs known to interact with Polytussin DM (dexchlorpheniramine / dextromethorphan / phenylephrine), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 89 are major, 450 are moderate, and 5 are minor.
- View all 544 medications that may interact with Polytussin DM
- View Polytussin DM alcohol/food interactions (2)
- View Polytussin DM disease interactions (8)
Most frequently checked interactions
View interaction reports for Polytussin DM (dexchlorpheniramine / dextromethorphan / phenylephrine) and the medicines listed below.
- acetaminophen
- Advil Liqui-Gels (ibuprofen)
- amlodipine
- amoxicillin / clavulanate
- aspirin
- atorvastatin
- azelastine nasal
- azithromycin
- Azithromycin Dose Pack (azithromycin)
- benzonatate
- bupropion
- cephalexin
- Claritin (loratadine)
- clonidine
- CoQ10 (ubiquinone)
- D3 (cholecalciferol)
- doxycycline
- escitalopram
- ezetimibe
- fluticasone nasal
- gabapentin
- guaifenesin
- hydroxyzine
- ibuprofen
- Lamictal (lamotrigine)
- methocarbamol
- multivitamin
- prednisone
- Vitamin D3 (cholecalciferol)
- Wellbutrin XL (bupropion)
Polytussin DM alcohol/food interactions
There are 2 alcohol/food interactions with Polytussin DM (dexchlorpheniramine / dextromethorphan / phenylephrine).
Polytussin DM disease interactions
There are 8 disease interactions with Polytussin DM (dexchlorpheniramine / dextromethorphan / phenylephrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- BPH
- diabetes
- glaucoma
More about Polytussin DM (dexchlorpheniramine / dextromethorphan / phenylephrine)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.